BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 17092865)

  • 1. Porokeratosis of Mibelli of the axillae: treatment with topical imiquimod.
    Montes-De-Oca-Sánchez G; Tirado-Sánchez A; García-Ramírez V
    J Dermatolog Treat; 2006; 17(5):319-20. PubMed ID: 17092865
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Porokeratosis of Mibelli: successful treatment with topical 5% imiquimod cream.
    Harrison S; Sinclair R
    Australas J Dermatol; 2003 Nov; 44(4):281-3. PubMed ID: 14616497
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Successful treatment of porokeratosis of Mibelli with imiquimod 5% cream.
    Jain S
    Clin Exp Dermatol; 2006 Mar; 31(2):302-3. PubMed ID: 16487129
    [No Abstract]   [Full Text] [Related]  

  • 4. Porokeratosis of Mibelli: Successful treatment with 5 percent topical imiquimod and topical 5 percent 5-fluorouracil.
    Venkatarajan S; LeLeux TM; Yang D; Rosen T; Orengo I
    Dermatol Online J; 2010 Dec; 16(12):10. PubMed ID: 21199636
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Case of linear porokeratosis: successful treatment with topical 5% imiquimod cream.
    Ahn SJ; Lee HJ; Chang SE; Lee MW; Choi JH; Moon KC; Koh JK
    J Dermatol; 2007 Feb; 34(2):146-7. PubMed ID: 17239156
    [No Abstract]   [Full Text] [Related]  

  • 6. Successful treatment of porokeratosis with topical imiquimod in 2 immunosuppressed cases.
    Erbagci Z; Tuncel AA; Erbagci I
    J Drugs Dermatol; 2006; 5(7):668-71. PubMed ID: 16865875
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A case of porokeratosis ptychotropica: successful treatment with topical 5% imiquimod cream.
    Kawakami Y; Mitsui S
    Clin Exp Dermatol; 2017 Oct; 42(7):839-841. PubMed ID: 28543397
    [No Abstract]   [Full Text] [Related]  

  • 8. Human papillomavirus isolated from transplant-associated porokeratoses of mibelli responsive to topical 5% imiquimod cream.
    Esser AC; Pittelkow MR; Randle HW
    Dermatol Surg; 2006 Jun; 32(6):858-61. PubMed ID: 16792657
    [No Abstract]   [Full Text] [Related]  

  • 9. Disseminated porokeratosis palmaris and plantaris treated with imiquimod cream to prevent malignancy.
    Jensen JM; Egberts F; Proksch E; Hauschild A
    Acta Derm Venereol; 2005; 85(6):550-1. PubMed ID: 16396815
    [No Abstract]   [Full Text] [Related]  

  • 10. Disseminated superficial actinic porokeratosis treated effectively with topical imiquimod 5% cream.
    Arun B; Pearson J; Chalmers R
    Clin Exp Dermatol; 2011 Jul; 36(5):509-11. PubMed ID: 21507038
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Porokeratosis of Mibelli: Involution and resolution with 5% imiquimod cream.
    Gajic B; Tang K; Whitfeld M
    Australas J Dermatol; 2011 Nov; 52(4):301-3. PubMed ID: 22070709
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Porokeratosis of Mibelli: successful treatment with 5% imiquimod cream.
    Agarwal S; Berth-Jones J
    Br J Dermatol; 2002 Feb; 146(2):338-9. PubMed ID: 11903259
    [No Abstract]   [Full Text] [Related]  

  • 13. Imiquimod and Photodynamic Therapy Are Useful in the Treatment of Porokeratosis in Children with Bone Marrow Transplantation.
    Gracia-Cazaña T; Vera-Álvarez J; García-Patos V; Gilaberte Y
    Pediatr Dermatol; 2015; 32(6):e291-3. PubMed ID: 26223374
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment of Porokeratosis: A Systematic Review.
    Weidner T; Illing T; Miguel D; Elsner P
    Am J Clin Dermatol; 2017 Aug; 18(4):435-449. PubMed ID: 28283894
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Determination of the area of skin capable of being covered by the application of 250 mg of 5% imiquimod cream.
    Berman B; Ricotti CA; Cazzaniga A; Davis SC
    Dermatol Surg; 2004 May; 30(5):784-6. PubMed ID: 15099325
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Successful treatment of keratoacanthoma centrifugum marginatum with local application of imiquimod cream.
    Aroni K; Mastoraki A; Agrogiannis G; Ioannidis E; Patsouris E
    Int J Dermatol; 2007 Dec; 46(12):1321-2. PubMed ID: 18173541
    [No Abstract]   [Full Text] [Related]  

  • 17. Imiquimod 5% cream for keloid management.
    Berman B; Villa A
    Dermatol Surg; 2003 Oct; 29(10):1050-1. PubMed ID: 12974703
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Randomized, double-blind clinical trial of topical imiquimod 5% with parenteral meglumine antimoniate in the treatment of cutaneous leishmaniasis in Peru.
    Miranda-Verástegui C; Llanos-Cuentas A; Arévalo I; Ward BJ; Matlashewski G
    Clin Infect Dis; 2005 May; 40(10):1395-403. PubMed ID: 15844060
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment of facial verrucae with topical imiquimod cream in a patient with human immunodeficiency virus.
    Cutler K; Kagen MH; Don PC; McAleer P; Weinberg JM
    Acta Derm Venereol; 2000; 80(2):134-5. PubMed ID: 10877136
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Transient effect of topical treatment of cutaneous leishmaniasis with imiquimod.
    Seeberger J; Daoud S; Pammer J
    Int J Dermatol; 2003 Jul; 42(7):576-9. PubMed ID: 12839616
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.